Research progress of regorafenib in the treatment of colorectal cancer

Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 9

Abstract

Colorectal cancer (CRC) is a common malignant tumor of digestive tract with an increasing incidence and mortality worldwide, and most patients have lost the opportunity of surgical treatment once diagnosed. With the continuous development of precision targeted therapy, anti-angiogenesis targeted drugs have achieved good therapeutic effect in the treatment of advanced CRC. Regorafenib is a multi-target oral tyrosine kinase inhibitor, which can improve the tumor immune microenvironment by regulating tumor-associated macrophage, vascular endothelial growth factor receptor, and has a synergistic effect with immunotherapy. This article reviews the progress of basic and clinical research on regorafenib in the field of CRC.

Authors and Affiliations

CHEN Yixuan, LEI Xuefen, ZHANG Meng, CHEN Qian, CHEN Haixia

Keywords

Related Articles

Effects of a systematic nursing model based on the concept of colour psychology on the psychological and survival quality of brain glioma

Objective To explore the effects of a systematic nursing model based on color psychology on the psychological and quality of life outcomes of patients with brain glioma. Methods 100 patients with brain glioma admitted to...

Genetic causes of isolated congenital heart disease

The genetic mechanism of congenital heart disease (CHD) is complex and currently lacks a clear understanding. Literature studies on CHD often report the presence of concurrent extracardiac anomalies, but since the majori...

Influencing factors of pathological complete response in triple-negative breast cancer with neoadjuvant chemotherapy

Objective To analyze the clinical and pathological factors affecting pathological complete response (pCR) of triple-negative breast cancer (TNBC) after neoadjuvant chemotherapy (NAC).  Methods A retrospective analysis wa...

Application of early cardiac rehabilitation combined with psychological nursing intervention in nursing care after PCI of acute coronary syndrome

Objective To observe the application effects of early cardiac rehabilitation combined with psychological care intervention after percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS). Me...

The value of surface immunoglobulin M detection in differentiating chronic lymphocytic leukemia and mantle cell lymphoma

Objective To investigate the application and significance of membrane surface immunoglobulin M (sIgM) in the differential diagnosis of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).  Methods The clini...

Download PDF file
  • EP ID EP745448
  • DOI 10.13429/j.cnki.cjcr.2024.09.002
  • Views 38
  • Downloads 0

How To Cite

CHEN Yixuan, LEI Xuefen, ZHANG Meng, CHEN Qian, CHEN Haixia (2024). Research progress of regorafenib in the treatment of colorectal cancer. Chinese Journal of Clinical Research, 37(9), -. https://europub.co.uk/articles/-A-745448